Yüklüyor......
MicroRNA‐140‐5p elevates cerebral protection of dexmedetomidine against hypoxic–ischaemic brain damage via the Wnt/β‐catenin signalling pathway
Hypoxia–ischaemia (HI) remains a major cause of foetal brain damage presented a scarcity of effective therapeutic approaches. Dexmedetomidine (DEX) and microRNA‐140‐5p (miR‐140‐5p) have been highlighted due to its potentially significant role in the treatment of cerebral ischaemia. This study was to...
Kaydedildi:
| Yayımlandı: | J Cell Mol Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5980153/ https://ncbi.nlm.nih.gov/pubmed/29536658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13597 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|